ライフサイエンスコーパス: acute renal failure

1 pathogen that causes hemorrhagic colitis and acute renal failure.

2 US is similar to TTP, but is associated with acute renal failure.

3 thic hemolytic anemia, thrombocytopenia, and acute renal failure.

4 mber of new therapies are in development for acute renal failure.

5 y provide a breakthrough in the treatment of acute renal failure.

6 eins, cyclophilin, attenuated sepsis-induced acute renal failure.

7 y and apoptotic insult during sepsis-induced acute renal failure.

8 athophysiology, prevention, and treatment of acute renal failure.

9 Attempts have been made to clearly define acute renal failure.

10 erular cells and is the most common cause of acute renal failure.

11 ons, are associated with a high incidence of acute renal failure.

12 eday offer the best option for recovery from acute renal failure.

13 olestatic liver diseases and the associating acute renal failure.

14 l animal models during or after the onset of acute renal failure.

15 of stem cell research might be used to treat acute renal failure.

16 promise for the proactive treatment of human acute renal failure.

17 a on current and promising new therapies for acute renal failure.

18 of IL-6 was investigated in murine ischemic acute renal failure.

19 thy, hemolytic anemia, thrombocytopenia, and acute renal failure.

20 6, and this IL-6 exacerbates ischemic murine acute renal failure.

21 ded clues towards accelerating recovery from acute renal failure.

22 herapy; the most common of these effects was acute renal failure.

23 ators of tissue damage in ischemic and toxic acute renal failure.

24 ay be useful for cell replacement therapy of acute renal failure.

25 es renal I/R injury and severity of ischemic acute renal failure.

26 ion injury (I/R injury) is a common cause of acute renal failure.

27 ated with several renal syndromes, including acute renal failure.

28 is common, and in some cases, can present as acute renal failure.

29 response, and alteration in polarity in the acute renal failure.

30 ng a novel therapeutic strategy for clinical acute renal failure.

31 nfection, bleeding or transfusion event, and acute renal failure.

32 review new insights into the pathogenesis of acute renal failure.

33 s may improve survival in some patients with acute renal failure.

34 reasingly popular as a choice of therapy for acute renal failure.

35 eloped thrombocytopenia, schistocytosis, and acute renal failure.

36 ient required postoperative hemodialysis for acute renal failure.

37 ction minimized ischemia-reperfusion-induced acute renal failure.

38 d a 2.5- to 4-fold higher risk of developing acute renal failure.

39 tor antagonist was associated with decreased acute renal failure.

40 d by hemolytic anemia, thrombocytopenia, and acute renal failure.

41 enia, microangiopathic hemolytic anemia, and acute renal failure.

42 y diarrhea with the potential to progress to acute renal failure.

43 alkalinization, and monitoring for signs of acute renal failure.

44 n into toxic products that ultimately causes acute renal failure.

45 ic or end-stage renal disease, and seven had acute renal failure.

46 li infection is a leading cause of pediatric acute renal failure.

47 (IRI), which is the major cause of intrinsic acute renal failure.

48 nfarction, diabetes, sepsis, and hepatic and acute renal failure.

49 n of xenon before renal ischemia can prevent acute renal failure.

50 iitis, resulting in pulmonary hemorrhage and acute renal failure.

51 l hemorrhage (1.6% versus 0.2%; P=0.03), and acute renal failure (13.9% versus 9.4%; P=0.02) were sig

52 7%), paraplegia (8.5%), bowel ischemia (7%), acute renal failure (21%), dialysis requirement (13%), a

53 related to treatment), pneumonia (27 [11%]), acute renal failure (25 [10%]; five related to treatment

54 omial infections (43% vs. 57%, p = .16), and acute renal failure (26% vs. 18%, p = .34).

55 (7 vs. 3), variceal hemorrhage (5 vs. 8), or acute renal failure (3 vs. 2).

56 The most common complication was acute renal failure (30.44% of cases).

57 rculatory support-related complications were acute renal failure 41%, bleeding 25%, neurologic damage

58 troke (14 [2.0%] and 15 [2.2%], P=0.79), and acute renal failure (42 [6.1%] and 35 [5.1%], P=0.45).

59 of death (2.3%, 0.8%, and 0.6%; P = .02) and acute renal failure (6.2%, 7.6%, and 2.4%; P < .001) aft

60 N1 influenza (8%), respiratory failure (8%), acute renal failure (7%), and acute respiratory distress

61 One example is acute renal failure, a major cause of morbidity and mort

62 r than ischemic or multifactorial) origin of acute renal failure, acute respiratory failure, and lowe

63 Acute renal failure (adjusted odds ratio [AOR], 3.01; 95

64 living donor kidney recipients who developed acute renal failure after exposure to sirolimus-tacrolim

65 eperfusion (I/R) injury is a common cause of acute renal failure after kidney transplantation.

66 Y720 reduced IRI and prevented unrecoverable acute renal failure after significant ischemic injury.

67 protect against or accelerate recovery from acute renal failure after the renal insult.

68 This degree of acute renal failure also increased length of stay by nea

69 syndrome (D+HUS) is the most common cause of acute renal failure among children.

70 A total of 101 patients (95.3%) had acute renal failure and 78 (73.6%) required renal replac

71 ns (eg, myocardial infarction, pneumonia, or acute renal failure and a length of stay >75th percentil

72 ns (eg, pneumonia, myocardial infarction, or acute renal failure and a length of stay >75th percentil

73 y diarrhea with the potential to progress to acute renal failure and central nervous system complicat

74 iations were strongest between ED visits for acute renal failure and heat waves defined by maximum ap

75 fusion injury (IRI) is a feature of ischemic acute renal failure and it impacts both short- and long-

76 This study examines the incidence of acute renal failure and its associated mortality and mor

77 hip between year of surgery and diagnosis of acute renal failure and mortality.

78 for these patients to prevent or ameliorate acute renal failure and reduce the need for RRT postoper

79 rhoea and urinary sepsis in one patient, and acute renal failure and respiratory failure in one patie

80 y well tolerated, with similar occurrence of acute renal failure and treatment-emergent serious adver

81 with significant protection from I/R-induced acute renal failure and tubular damage.

82 ts (pneumonia, myelodysplastic syndrome, and acute renal failure) and two in the treatment of physici

83 at care for a larger number of patients with acute renal failure, and black patients had lower in-hos

84 acheitis, encephalopathy, bacteremia/sepsis, acute renal failure, and myocarditis were rare (each </=

85 in-hospital events (death, stroke, bleeding, acute renal failure, and need for permanent pacemaker) w

86 nervous system, leading to bloody diarrhea, acute renal failure, and neurological complications.

87 el disease, critical illness, liver failure, acute renal failure, and organ transplantation.

88 pathogenesis of sepsis, glomerulonephritis, acute renal failure, and other inflammatory processes.

89 opathy, adult respiratory distress syndrome, acute renal failure, and sepsis.

90 Renal ischemia-reperfusion injury causes acute renal failure, and the hallmarks of renal ischemia

91 imately 50%), ileus ( approximately 2 days), acute renal failure ( approximately 30%), and blood loss

92 The risk of mortality associated with acute renal failure (ARF) after open-heart surgery conti

93 ims databases may be useful for the study of acute renal failure (ARF) and ARF that requires dialysis

94 Sepsis is a major cause of acute renal failure (ARF) and death.

95 Ischemia reperfusion injury leading to acute renal failure (ARF) and delayed graft function is

96 R) injury of the kidney is a common cause of acute renal failure (ARF) and is associated with high mo

97 Kidneys from deceased donors with acute renal failure (ARF) are generally not accepted for

98 Acute renal injury (ARI) and acute renal failure (ARF) are serious complications afte

99 the incidence and prognostic implications of acute renal failure (ARF) are unknown.

100 nown that, among human patients with sepsis, acute renal failure (ARF) dramatically increases mortali

101 Patients with acute renal failure (ARF) experience a high mortality ra

102 The long-term effects of ischemic acute renal failure (ARF) following uninephrectomy are u

103 Acute renal failure (ARF) has high mortality and no effe

104 e prediction of adverse clinical outcomes in acute renal failure (ARF) has not been well described.

105 have concluded that outcomes associated with acute renal failure (ARF) have not improved significantl

106 Acute renal failure (ARF) in low-flow states may be reve

107 to determine the incidence and mortality of acute renal failure (ARF) in Medicare beneficiaries.

108 ported that rapamycin impairs recovery after acute renal failure (ARF) in rats.

109 nd to bovine serum albumin ameliorate murine acute renal failure (ARF) induced by temporary occlusion

110 Acute renal failure (ARF) is a common life-threatening c

111 Acute renal failure (ARF) is a syndrome that occurs when

112 Clinical studies demonstrate that acute renal failure (ARF) is associated with increased m

113 Progress in treating human acute renal failure (ARF) is dependent on developing tec

114 kidneys recovered from deceased donors with acute renal failure (ARF) is higher compared with those

115 ration (CVVHDF) on survival in patients with acute renal failure (ARF) is unknown.

116 The mortality rate for patients with acute renal failure (ARF) remains unacceptably high.

117 We therefore hypothesized that LPS-induced acute renal failure (ARF) requires systemic TNF release

118 Acute renal failure (ARF) secondary to ischemic injury r

119 Acute renal failure (ARF) sensitizes the kidney to endot

120 Acute renal failure (ARF) seriously worsens prognosis of

121 Treatment of acute renal failure (ARF) would be enhanced by identific

122 Acute renal failure (ARF), characterized by sudden loss

123 ction of postoperative 180-day mortality and acute renal failure (ARF), improving upon predictions th

124 Acute renal failure (ARF), recently renamed acute kidney

125 Acute renal failure (ARF), resulting from ischemic or to

126 e proinflammatory cytokine IL-18 in ischemic acute renal failure (ARF), we report here on the effect

127 Among the 31 patients, 21 presented with acute renal failure (ARF), were normocalcemic, and had a

128 species are important mediators of injury in acute renal failure (ARF).

129 nt of cellular damage after ischemia-induced acute renal failure (ARF).

130 osis occurs in the kidney during LPS-induced acute renal failure (ARF).

131 in sepsis, a condition often accompanied by acute renal failure (ARF).

132 can cause bloody diarrhea and, occasionally, acute renal failure as a consequence of Shiga toxin (Stx

133 tested the hypothesis that the diagnosis of acute renal failure associated with coronary artery bypa

134 We conclude that the nationwide trend of acute renal failure associated with coronary artery bypa

135 nists has been implicated in protection from acute renal failure associated with radiocontrast media

136 EPO can ameliorate ischaemic and nephrotoxic acute renal failure, Bahlmann's work is the first eviden

137 a novel therapeutic intervention in ischemic acute renal failure, based at least in part on its abili

138 In stratified analyses of patients with acute renal failure, black patients had significantly lo

139 rest, coma >24 hours, myocardial infarction, acute renal failure, bleeding requiring >4 units of red

140 Many show promise in animal models of acute renal failure but prospective studies in humans ar

141 udy, the role of exogenous HGF in preventing acute renal failure by systemic administration of naked

142 dopamine for the treatment or prevention of acute renal failure cannot be justified on the basis of

143 % (95% confidence interval [CI], 67%-91%) of acute renal failure cases compared with 38% (95% CI, 25%

144 The proportion of acute renal failure cases that required dialysis decreas

145 Acute renal failure causes considerable morbidity and mo

146 SLE who presented with pulmonary hemorrhage, acute renal failure, change in mental status, and severe

147 isease, the incidence of secondary causes of acute renal failure continue to grow, especially in pati

148 Acute renal failure continues to complicate the postoper

149 s grafted into WT recipients (n=7) developed acute renal failure (control group), WT grafts transplan

150 Incidence of acute renal failure decreased in the PBM cohort (2.39% v

151 30 mL/min who received a high dose of GBCA, acute renal failure, delayed hemodialysis after contrast

152 Acute renal failure developing after orthotopic liver tr

153 The incidence of acute renal failure diagnosis increased significantly du

154 ndings suggest that the observed increase in acute renal failure diagnosis rates may be partly attrib

155 ttributable to less restrictive criteria for acute renal failure diagnosis, consistent with acute ren

156 further assess the role of BAK in sepsis in acute renal failure, dogs were nephrectomized and 48 h l

157 5) on deviant days for heat-related illness, acute renal failure, electrolyte imbalance, and nephriti

158 tions, particularly in splenectomized cases, acute renal failure, Evans syndrome, and multitreatment

159 reased susceptibility to hospitalization for acute renal failure for blacks, Hispanics, people aged 2

160 Acute renal failure frequently occurs in the intensive c

161 Acute renal failure from both ischemia and contrast are

162 eceived N-acetylcysteine had an incidence of acute renal failure (>or=0.5 mg/dL increase in creatinin

163 diffuse neurologic deficit, amaurosis fugax, acute renal failure, gut ischemia, livedo reticularis an

164 Depending on the definition used, acute renal failure has been reported to affect from 1%

165 The therapy of acute renal failure has changed substantially during the

166 The scarcity of early biomarkers for acute renal failure has hindered our ability to launch p

167 A precise biochemical definition of acute renal failure has never been proposed, and until r

168 ology and insight into mechanisms leading to acute renal failure have triggered investigators to eval

169 luded congenital heart disease, age >/=1 yr, acute renal failure, hepatic insufficiency, and sepsis.

170 Secondary endpoints included acute renal failure, hyperkalemia, the prevalence of hyp

171 Preventing acute renal failure, improving clinical outcomes of the

172 ADV nephritis was associated with acute renal failure in 90% of the infected patients.

173 SC reduced the severity of cisplatin-induced acute renal failure in adult female mice.

174 eperfusion injury (IRI) is the main cause of acute renal failure in both allograft and native kidney.

175 yndrome, which is the most frequent cause of acute renal failure in children in the Americas and Euro

176 ome (HUS), which is the most common cause of acute renal failure in children in the United States.

177 There are many different causes of acute renal failure in children, including prerenal dise

178 erichia coli and is the most common cause of acute renal failure in children.

179 chia coli infection, is the leading cause of acute renal failure in children.

180 auses of hemolytic uremic syndrome (HUS) and acute renal failure in children.

181 c syndrome (HUS) is the most common cause of acute renal failure in children.

182 the most common causes of hospital acquired acute renal failure in children.

183 IAH/ACS is an important possible cause of acute renal failure in critically ill patients and scree

184 te renal failure is the most common cause of acute renal failure in hospitalized patients and has an

185 se events have failed to alter the course of acute renal failure in human trials.

186 c syndrome (HUS) is the most common cause of acute renal failure in infants and young children, and i

187 We studied acute renal failure in patients hospitalized between 200

188 here were trends toward reduced incidence of acute renal failure in patients with baseline Sequential

189 Trends toward reduced incidence of acute renal failure in patients with baseline SOFA score

190 c glomerulonephritis (TGN), a known cause of acute renal failure in patients.

191 ly discuss the epidemiology and incidence of acute renal failure in pediatric patients and review new

192 Ideal care for women with acute renal failure in pregnancy or postpartum requires

193 our understanding of the pathophysiology of acute renal failure in pregnancy where plasma androgen l

194 ing the frequency of acute kidney injury and acute renal failure in the critically ill.

195 A total of 605 patients with acute renal failure in the intensive care unit during 19

196 replacement therapy over the past few years, acute renal failure in the intensive care unit remains a

197 s, the most common condition associated with acute renal failure in the intensive care unit, may alte

198 udies have suggested a variable incidence of acute renal failure in this population, with an associat

199 Nonhematologic toxicity was grade 3 acute renal failure in two patients; grade 3 electrolyte

200 hagic Escherichia coli is the major cause of acute renal failure in young children.

201 Acute renal failure is a common complication in critical

202 Acute renal failure is a rare complication of pregnancy

203 Acute renal failure is associated with high mortality an

204 Acute renal failure is characterized by an increase in t

205 racial differences exist in mortality after acute renal failure is not known.

206 Ischemic acute renal failure is the most common cause of acute re

207 nces in understanding the pathophysiology of acute renal failure, little progress has been made in it

208 The incidence of acute renal failure may be increasing and the mortality

209 pment of sensitive, predictive biomarkers of acute renal failure may help to diagnose the syndrome ea

210 (n = 2), gastric outlet obstruction (n = 1), acute renal failure (n = 2), pneumonia (n = 2), respirat

211 possible exception of radio-contrast-induced acute renal failure, no drugs are capable of preventing

212 Acute renal failure occurred in 15 (58%) of 26 patients.

213 Acute renal failure occurs frequently in hospitalized pa

214 scitation on multivariable analysis included acute renal failure (odds ratio 1.5, 95% confidence inte

215 io 36.6, 95% confidence interval 21.9-61.0), acute renal failure (odds ratio 21.6, 95% confidence int

216 ly associated with clinical failure included acute renal failure (odds ratio [OR], 3.91 [95% confiden

217 ppears to be the initiating event behind the acute renal failure of familial HUS patients.

218 ted with high rates of in-hospital death and acute renal failure, often requiring dialysis.

219 The impact of acute renal failure on mortality, length of stay, and ch

220 rate (eGFR) lower than 30 mL/min, and 11 had acute renal failure or acute deterioration of chronic re

221 inflammatory state, more specific effects of acute renal failure or chronic kidney disease, and effec

222 onged ventilation), and renal complications (acute renal failure or insufficiency).

223 en expended to develop techniques to prevent acute renal failure or to facilitate its resolution.

224 th (OR 7.8, 95% CI 4.2 to 14.7; p < 0.0001), acute renal failure (OR 2.8, 95% CI 1.4 to 5.7; p = 0.00

225 y (OR, 8.6; 95% CI, 3.9-18.8; P < .001), and acute renal failure (OR, 10.5; 95% CI, 3.8-29.3; P < .00

226 mia (OR, 9.03; 95% CI, 3.49-23.38; P<0.001), acute renal failure (OR, 3.61; 95% CI, 1.68-7.75; P=0.00

227 hromboembolism (OR:2.11; 95% CI: 1.70-2.61), acute renal failure (OR: 1.34; 95% CI; 1.22-1.47), and s

228 peracillin" and "tazobactam"] and ["AKI" or "acute renal failure" or "nephrotoxicity"] and registered

229 peracillin" and "tazobactam"] and ["AKI" or "acute renal failure" or "nephrotoxicity"] and registered

230 ents with a subarachnoid hemorrhage, trauma, acute renal failure, or severe community-acquired pneumo

231 e (P<0.0001), need for laparotomy (P<0.008), acute renal failure (P<0.0001), need for dialysis (P<0.0

232 ute renal failure diagnosis, consistent with acute renal failure patterns observed in other clinical

233 l 9% increase in odds of hospitalization for acute renal failure per 5 degrees F (2.78 degrees C) was

234 nts that were deemed unrelated to alectinib: acute renal failure; pleural effusion and pericardial ef

235 k for postoperative complications, including acute renal failure, pneumonia, bleeding, septicemia, st

236 Notably, acute renal failure predicted worse outcomes and perform

237 tive risk, 1.42; P<0.001), and postoperative acute renal failure (relative risk, 2.13; P<0.001).

238 Mortality rates in acute renal failure remain extremely high, and risk-adju

239 Despite declining mortality, acute renal failure remains a burden on healthcare resou

240 Acute tubular necrosis secondary to ischemic acute renal failure remains a common clinical problem wi

241 Acute renal failure remains a common complication of non

242 Acute renal failure remains a major complication of coro

243 Acute renal failure remains a significant cause of morbi

244 ents for each sample was 2% (39 of 1924) for acute renal failure requiring dialysis, 0.7% (18 of 2327

245 Similarly, among those with acute renal failure requiring dialysis, black patients h

246 Postoperative occurrences of acute renal failure requiring dialysis, deep vein thromb

247 Acute renal failure requiring renal replacement therapy

248 Acute renal failure requiring renal replacement therapy

249 ute respiratory distress syndrome (ARDS) and acute renal failure, requiring mechanical ventilation, v

250 replaced the terms chronic renal failure and acute renal failure, respectively.

251 enal solid organ transplants are at risk for acute renal failure resulting from cardiac or hepatic fa

252 Acute renal failure resulting from hypoperfusion and hyp

253 Acute renal failure results in significant morbidity and

254 (RR=12.17 [95% CI 1.3-117.2], P=0.007), and acute renal failure (RR=11.8 [95% CI 2.9-48.8], P<0.001)

255 Acute renal failure secondary to ischemic injury remains

256 se, presenting with profound hypotension and acute renal failure, secondary to hypovolemic shock.

257 , including myocardial infarction, diabetes, acute renal failure, sepsis, and acute lung injury.

258 s associated with failure to rescue included acute renal failure, septic shock, and postoperative pul

259 ncluded bacteremia, pulmonary complications, acute renal failure, shock, intensive care unit admissio

260 of diuretics in critically ill patients with acute renal failure should be discouraged.

261 performance metrics to six generic and four acute renal failure-specific predictive models.

262 in comorbid disease burden, mortality in the acute renal failure subgroup declined from 39.5% to 17.9

263 The percentage of acute renal failure survivors with postdischarge special

264 one (0.7%) group were less likely to develop acute renal failure than those randomized to placebo (5.

265 l mortality is lower for black patients with acute renal failure than white patients.

266 Five additional patients with acute renal failure that was caused by cast nephropathy

267 We found no increase in the incidence of acute renal failure, the frequency of intensive care uni

268 This review will focus on hypoxic/ischemic acute renal failure, the most common causes of hospital

269 herapies for the treatment and prevention of acute renal failure, there are reasons to be optimistic.

270 microvasculature by platelet-fibrin thrombi, acute renal failure, thrombocytopenia, microvascular hem

271 The patient developed acute renal failure, thrombocytopenia, transaminitis, an

272 Exclusion criteria were acute renal failure, trauma, and surgery within 2 days.

273 of death, myocardial infarction, stroke, or acute renal failure up to the time of hospital discharge

274 a relatively clear benchmark for diagnosing acute renal failure, use of alternate criteria to define

275 ife-threatening disease often accompanied by acute renal failure, usually occurs after gastrointestin

276 lung transplant recipients, the incidence of acute renal failure was 25%, with 8% of patients requiri

277 of diuretics in critically ill patients with acute renal failure was associated with an increased ris

278 Index acute renal failure was associated with increased odds o

279 The incidence of acute renal failure was higher among KT patients (40.9%

280 Acute renal failure was induced by 5 mg/kg subcutaneous

281 Rhabdomyolysis-induced acute renal failure was induced in mice by glycerol inje

282 =7), where the protection from postoperative acute renal failure was no greater than in mice with MAS

283 In the latter patient, acute renal failure was not suspected to be related to e

284 ients who did not require renal replacement, acute renal failure was strongly associated with increas

285 ative pathway, to protect mice from ischemic acute renal failure was tested.

286 eptor activity is required for recovery from acute renal failure, we examined the role of the EGF rec

287 esult of diabetic nephropathy presented with acute renal failure, weakness, myalgia, and pigmented ur

288 ry failure, major cardiac complications, and acute renal failure were associated with an increased mo

289 tus, congestive heart failure, or chronic or acute renal failure were identified as high-risk patient

290 dothelial injury, glomerular thrombosis, and acute renal failure were markedly attenuated despite the

291 The NSF incidence in the patients with acute renal failure who received a high dose when their

292 h no-balanced fluids: in-hospital mortality, acute renal failure with and without dialysis, and hospi

293 pio) developed thrombocytopenia, anemia, and acute renal failure with loss of glomerular function, in

294 ed by hemolytic anemia, thrombocytopenia and acute renal failure with multiple organ involvement.

295 its contribution to acute kidney injury and acute renal failure with regard to intra-abdominal press

296 significant differences in the prevalence of acute renal failure (with and without dialysis) or in-ho

297 nia, dehydration, heat stroke, diabetes, and acute renal failure, with a 10 degrees F increase in sam

298 of a pathogenic role for B cells in ischemic acute renal failure, with a serum factor as a potential

299 a, approximately 10% have dialysis-dependent acute renal failure, with cast nephropathy, caused by mo

300 on of anti-GEN antibodies into mice leads to acute renal failure, with glomerular and tubular injury.